ACS 化学神经科学分子聚焦贝卡司他（GSI-953）。
ACS chemical neuroscience molecule spotlight on Begacestat (GSI-953).
机构信息
Vanderbilt Center for Neuroscience Drug Discovery, Department of Pharmacology and Chemistry, Vanderbilt University Medical Center, Vanderbilt University , Nashville, Tennessee 37232-6600, United States.
出版信息
ACS Chem Neurosci. 2012 Jan 18;3(1):3-4. doi: 10.1021/cn200124u.
Abstract
A "second generation" γ-secretase, Begacestat (GSI-953), which is more selective against Notch-signaling, has shown promise in recent Phase I clinical trials. Begacestat, a novel, 2,5-disubsitituted thiophene sulfonamide from Wyeth (now Pfizer) is under evaluation for the treatment of Alzheimer's disease.
摘要
一种“第二代”γ-分泌酶，贝卡斯特（GSI-953），对 Notch 信号具有更高的选择性，在最近的 I 期临床试验中显示出了前景。贝卡斯特是惠氏（现为辉瑞）的一种新型 2,5-二取代噻吩磺酰胺，正在评估用于治疗阿尔茨海默病。
相似文献
1
ACS chemical neuroscience molecule spotlight on Begacestat (GSI-953).ACS 化学神经科学分子聚焦贝卡司他（GSI-953）。
ACS Chem Neurosci. 2012 Jan 18;3(1):3-4. doi: 10.1021/cn200124u.
2
Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's disease.贝加西他（GSI-953）：一种新型的、选择性的噻吩磺酰胺类淀粉样前体蛋白γ-分泌酶抑制剂，用于治疗阿尔茨海默病。
J Pharmacol Exp Ther. 2009 Nov;331(2):598-608. doi: 10.1124/jpet.109.152975. Epub 2009 Aug 11.
3
Discovery of begacestat, a Notch-1-sparing gamma-secretase inhibitor for the treatment of Alzheimer's disease.用于治疗阿尔茨海默病的Notch-1保留型γ-分泌酶抑制剂贝加西他的发现。
J Med Chem. 2008 Dec 11;51(23):7348-51. doi: 10.1021/jm801252w.
4
ACS chemical neuroscience molecule spotlight on BMS-708163.ACS 化学神经科学分子特写：BMS-708163。
ACS Chem Neurosci. 2012 Mar 21;3(3):149-50. doi: 10.1021/cn3000179.
5
[Alzheimer's disease treatment by inhibition/modulation of the gamma-secretase activity].通过抑制/调节γ-分泌酶活性治疗阿尔茨海默病
Rinsho Shinkeigaku. 2009 Nov;49(11):845-7. doi: 10.5692/clinicalneurol.49.845.
6
Design, synthesis, and evaluation of tetrahydroquinoline and pyrrolidine sulfonamide carbamates as gamma-secretase inhibitors.作为γ-分泌酶抑制剂的四氢喹啉和吡咯烷磺酰胺氨基甲酸酯的设计、合成及评估
Bioorg Med Chem Lett. 2007 Jun 1;17(11):3010-3. doi: 10.1016/j.bmcl.2007.03.055. Epub 2007 Mar 23.
7
An improved cell-based method for determining the γ-secretase enzyme activity against both Notch and APP substrates.一种改良的基于细胞的方法，用于测定针对 Notch 和 APP 底物的 γ-分泌酶酶活性。
J Neurosci Methods. 2013 Feb 15;213(1):14-21. doi: 10.1016/j.jneumeth.2012.11.011. Epub 2012 Dec 7.
8
Substituted 4-morpholine N-arylsulfonamides as γ-secretase inhibitors.取代 4-吗啉 N-芳基磺酰胺类化合物作为 γ-分泌酶抑制剂。
Eur J Med Chem. 2016 Nov 29;124:36-48. doi: 10.1016/j.ejmech.2016.08.024. Epub 2016 Aug 13.
9
Synthesis and structure-activity relationship of a novel series of heterocyclic sulfonamide gamma-secretase inhibitors.新型杂环磺酰胺γ-分泌酶抑制剂的合成及其构效关系
Bioorg Med Chem. 2009 Jul 1;17(13):4708-17. doi: 10.1016/j.bmc.2009.04.052. Epub 2009 May 3.
10
In vivo manifestation of Notch related phenotypes in zebrafish treated with Alzheimer's amyloid reducing gamma-secretase inhibitors.阿尔茨海默病淀粉样斑块减少型γ-分泌酶抑制剂处理的斑马鱼体内 Notch 相关表型的体内表现。
J Neurochem. 2010 Jun;113(5):1200-9. doi: 10.1111/j.1471-4159.2010.06681.x. Epub 2010 Mar 12.
引用本文的文献
1
γ-secretase targeting in Alzheimer's disease.针对阿尔茨海默病的γ-分泌酶靶向治疗
J Alzheimers Dis Rep. 2025 Jun 23;9:25424823251349529. doi: 10.1177/25424823251349529. eCollection 2025 Jan-Dec.
2
Review on anti-alzheimer drug development: approaches, challenges and perspectives.抗阿尔茨海默病药物研发综述：方法、挑战与展望
RSC Adv. 2024 Apr 5;14(16):11057-11088. doi: 10.1039/d3ra08333k. eCollection 2024 Apr 3.
3
Small-molecule drugs development for Alzheimer's disease.用于阿尔茨海默病的小分子药物研发
Front Aging Neurosci. 2022 Nov 1;14:1019412. doi: 10.3389/fnagi.2022.1019412. eCollection 2022.
4
Conformational Models of APP Processing by Gamma Secretase Based on Analysis of Pathogenic Mutations.基于对致病性突变的分析的 γ-分泌酶对 APP 加工的构象模型。
Int J Mol Sci. 2021 Dec 18;22(24):13600. doi: 10.3390/ijms222413600.
5
An Overview of Several Inhibitors for Alzheimer's Disease: Characterization and Failure.几种阿尔茨海默病抑制剂概述：特征与失败。
Int J Mol Sci. 2021 Oct 6;22(19):10798. doi: 10.3390/ijms221910798.
6
Visible-light mediated carbonyl trifluoromethylative amination as a practical method for the synthesis of β-trifluoromethyl tertiary alkylamines.可见光介导的羰基三氟甲基化胺化反应：一种合成β-三氟甲基叔烷基胺的实用方法
Chem Sci. 2020 Oct 9;11(44):12089-12094. doi: 10.1039/d0sc04853d.
7
Computational modeling and biomarker studies of pharmacological treatment of Alzheimer's disease (Review).计算建模与生物标志物研究在阿尔茨海默病药物治疗中的应用（综述）。
Mol Med Rep. 2018 Jul;18(1):639-655. doi: 10.3892/mmr.2018.9044. Epub 2018 May 22.
8
Quantitative Measurement of γ-Secretase-mediated Amyloid Precursor Protein and Notch Cleavage in Cell-based Luciferase Reporter Assay Platforms.基于细胞的荧光素酶报告基因检测平台中γ-分泌酶介导的淀粉样前体蛋白和Notch切割的定量测定
J Vis Exp. 2018 Jan 25(131):56795. doi: 10.3791/56795.
9
ACS chemical neuroscience molecule spotlight on BMS-708163.ACS 化学神经科学分子特写：BMS-708163。
ACS Chem Neurosci. 2012 Mar 21;3(3):149-50. doi: 10.1021/cn3000179.
本文引用的文献
1
ACS chemical neuroscience molecule spotlight on ELND006: another γ-secretase inhibitor fails in the clinic.ACS 化学生物学神经科学分子聚焦 ELND006：另一种 γ-分泌酶抑制剂在临床中失败。
ACS Chem Neurosci. 2011 Jun 15;2(6):279-80. doi: 10.1021/cn2000469.
2
ACS chemical neuroscience molecule spotlight on semagacestat (LY450139).ACS 化学生物学分子聚焦：司美格鲁肽（LY450139）。
ACS Chem Neurosci. 2010 Aug 18;1(8):533-4. doi: 10.1021/cn1000606.
3
Begacestat (GSI-953): a novel, selective thiophene sulfonamide inhibitor of amyloid precursor protein gamma-secretase for the treatment of Alzheimer's disease.贝加西他（GSI-953）：一种新型的、选择性的噻吩磺酰胺类淀粉样前体蛋白γ-分泌酶抑制剂，用于治疗阿尔茨海默病。
J Pharmacol Exp Ther. 2009 Nov;331(2):598-608. doi: 10.1124/jpet.109.152975. Epub 2009 Aug 11.
4
(S)-N-(5-Chlorothiophene-2-sulfonyl)-beta,beta-diethylalaninol a Notch-1-sparing gamma-secretase inhibitor.（S）-N-（5-氯噻吩-2-磺酰基）-β，β-二乙基丙氨酸是一种 Notch-1 非选择性 γ-分泌酶抑制剂。
Bioorg Med Chem Lett. 2009 Feb 1;19(3):926-9. doi: 10.1016/j.bmcl.2008.11.116. Epub 2008 Dec 6.
5
Discovery of begacestat, a Notch-1-sparing gamma-secretase inhibitor for the treatment of Alzheimer's disease.用于治疗阿尔茨海默病的Notch-1保留型γ-分泌酶抑制剂贝加西他的发现。
J Med Chem. 2008 Dec 11;51(23):7348-51. doi: 10.1021/jm801252w.
6
Discovery of a novel series of Notch-sparing gamma-secretase inhibitors.新型保留Notch功能的γ-分泌酶抑制剂系列的发现。
Bioorg Med Chem Lett. 2008 Jul 15;18(14):4232-6. doi: 10.1016/j.bmcl.2008.05.064. Epub 2008 May 20.
7
The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics.阿尔茨海默病的淀粉样蛋白假说：治疗之路上的进展与问题
Science. 2002 Jul 19;297(5580):353-6. doi: 10.1126/science.1072994.
8
The molecular pathology of Alzheimer's disease.阿尔茨海默病的分子病理学
Neuron. 1991 Apr;6(4):487-98. doi: 10.1016/0896-6273(91)90052-2.
9
Alzheimer's disease: the amyloid cascade hypothesis.阿尔茨海默病：淀粉样蛋白级联假说
Science. 1992 Apr 10;256(5054):184-5. doi: 10.1126/science.1566067.
Zotero 插件